Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • On-demand Webinar

What to expect with Amendment 2 IEC 60601-1 and Related Collaterals

UL expert, Pamela Gwynn, reviews the 2nd amendment to IEC 60601-1 standard and how it related to healthcare manufacturers.

Medical Devices and Products
THE CONTENT OF THIS WEBINAR IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT INTENDED TO CONVEY LEGAL OR OTHER PROFESSIONAL ADVICE.

Any changes to a standard can create concern within a company on the effects it will have on their products. The concern is even greater for medical device manufacturers that must show compliance to the new standard once the regulatory bodies set a date.

In this session, we will discuss the changes that are expected with Amendment 2, of the IEC 60601-1 standard, to allow you to start thinking about how this will affect your products. We will cover the high level changes occurring to the standard. With any amendment to the base standard, it will have other effects. We will additionally discuss the other effect the amendment will have to the 60601 series of standards.

SPEAKER:
Pamela Gwynn
Healthcare Principal Engineer
UL LLC